Cargando…

PPARGC1α gene DNA methylation variations in human placenta mediate the link between maternal hyperglycemia and leptin levels in newborns

BACKGROUND: Children exposed to gestational diabetes mellitus (GDM) are at a higher risk of developing obesity and type 2 diabetes. This susceptibility might involve brown adipose tissue (BAT), which is suspected to protect against obesity. The objective of this study is to assess whether fetal expo...

Descripción completa

Detalles Bibliográficos
Autores principales: Côté, Sandra, Gagné-Ouellet, Valérie, Guay, Simon-Pierre, Allard, Catherine, Houde, Andrée-Anne, Perron, Patrice, Baillargeon, Jean-Patrice, Gaudet, Daniel, Guérin, Renée, Brisson, Diane, Hivert, Marie-France, Bouchard, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918074/
https://www.ncbi.nlm.nih.gov/pubmed/27340502
http://dx.doi.org/10.1186/s13148-016-0239-9
_version_ 1782439053977714688
author Côté, Sandra
Gagné-Ouellet, Valérie
Guay, Simon-Pierre
Allard, Catherine
Houde, Andrée-Anne
Perron, Patrice
Baillargeon, Jean-Patrice
Gaudet, Daniel
Guérin, Renée
Brisson, Diane
Hivert, Marie-France
Bouchard, Luigi
author_facet Côté, Sandra
Gagné-Ouellet, Valérie
Guay, Simon-Pierre
Allard, Catherine
Houde, Andrée-Anne
Perron, Patrice
Baillargeon, Jean-Patrice
Gaudet, Daniel
Guérin, Renée
Brisson, Diane
Hivert, Marie-France
Bouchard, Luigi
author_sort Côté, Sandra
collection PubMed
description BACKGROUND: Children exposed to gestational diabetes mellitus (GDM) are at a higher risk of developing obesity and type 2 diabetes. This susceptibility might involve brown adipose tissue (BAT), which is suspected to protect against obesity. The objective of this study is to assess whether fetal exposure to maternal hyperglycemia is associated with DNA methylation variations in genes involved in BAT genesis and activation. METHODS: DNA methylation levels at the PRDM16, BMP7, CTBP2, and PPARGC1α gene loci were measured in placenta samples using bisulfite pyrosequencing in E-21 (n = 133; 33 cases of GDM) and the HumanMethylation450 array in Gen3G (n = 172, all from non-diabetic women) birth cohorts. Glucose tolerance was assessed in all women using an oral glucose tolerance test at the second trimester of pregnancy. Participating women were extensively phenotyped throughout pregnancy, and placenta and cord blood samples were collected at birth. RESULTS: We report that maternal glycemia at the second and third trimester of pregnancy are correlated with variations in DNA methylation levels at PRDM16, BMP7, and PPARGC1α and with cord blood leptin levels. Variations in PRDM16 and PPARGC1α DNA methylation levels were also correlated with cord blood leptin levels. Mediation analyses support that DNA methylation variations at the PPARGC1α gene locus explain 0.8 % of the cord blood leptin levels variance independently of maternal fasting glucose levels (p = 0.05). CONCLUSIONS: These results suggest that maternal glucose in pregnancy could produce variations in DNA methylation in BAT-related genes and that some of these DNA methylation marks seem to mediate the impact of maternal glycemia on cord blood leptin levels, an adipokine regulating body weight. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-016-0239-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4918074
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49180742016-06-24 PPARGC1α gene DNA methylation variations in human placenta mediate the link between maternal hyperglycemia and leptin levels in newborns Côté, Sandra Gagné-Ouellet, Valérie Guay, Simon-Pierre Allard, Catherine Houde, Andrée-Anne Perron, Patrice Baillargeon, Jean-Patrice Gaudet, Daniel Guérin, Renée Brisson, Diane Hivert, Marie-France Bouchard, Luigi Clin Epigenetics Research BACKGROUND: Children exposed to gestational diabetes mellitus (GDM) are at a higher risk of developing obesity and type 2 diabetes. This susceptibility might involve brown adipose tissue (BAT), which is suspected to protect against obesity. The objective of this study is to assess whether fetal exposure to maternal hyperglycemia is associated with DNA methylation variations in genes involved in BAT genesis and activation. METHODS: DNA methylation levels at the PRDM16, BMP7, CTBP2, and PPARGC1α gene loci were measured in placenta samples using bisulfite pyrosequencing in E-21 (n = 133; 33 cases of GDM) and the HumanMethylation450 array in Gen3G (n = 172, all from non-diabetic women) birth cohorts. Glucose tolerance was assessed in all women using an oral glucose tolerance test at the second trimester of pregnancy. Participating women were extensively phenotyped throughout pregnancy, and placenta and cord blood samples were collected at birth. RESULTS: We report that maternal glycemia at the second and third trimester of pregnancy are correlated with variations in DNA methylation levels at PRDM16, BMP7, and PPARGC1α and with cord blood leptin levels. Variations in PRDM16 and PPARGC1α DNA methylation levels were also correlated with cord blood leptin levels. Mediation analyses support that DNA methylation variations at the PPARGC1α gene locus explain 0.8 % of the cord blood leptin levels variance independently of maternal fasting glucose levels (p = 0.05). CONCLUSIONS: These results suggest that maternal glucose in pregnancy could produce variations in DNA methylation in BAT-related genes and that some of these DNA methylation marks seem to mediate the impact of maternal glycemia on cord blood leptin levels, an adipokine regulating body weight. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-016-0239-9) contains supplementary material, which is available to authorized users. BioMed Central 2016-06-22 /pmc/articles/PMC4918074/ /pubmed/27340502 http://dx.doi.org/10.1186/s13148-016-0239-9 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Côté, Sandra
Gagné-Ouellet, Valérie
Guay, Simon-Pierre
Allard, Catherine
Houde, Andrée-Anne
Perron, Patrice
Baillargeon, Jean-Patrice
Gaudet, Daniel
Guérin, Renée
Brisson, Diane
Hivert, Marie-France
Bouchard, Luigi
PPARGC1α gene DNA methylation variations in human placenta mediate the link between maternal hyperglycemia and leptin levels in newborns
title PPARGC1α gene DNA methylation variations in human placenta mediate the link between maternal hyperglycemia and leptin levels in newborns
title_full PPARGC1α gene DNA methylation variations in human placenta mediate the link between maternal hyperglycemia and leptin levels in newborns
title_fullStr PPARGC1α gene DNA methylation variations in human placenta mediate the link between maternal hyperglycemia and leptin levels in newborns
title_full_unstemmed PPARGC1α gene DNA methylation variations in human placenta mediate the link between maternal hyperglycemia and leptin levels in newborns
title_short PPARGC1α gene DNA methylation variations in human placenta mediate the link between maternal hyperglycemia and leptin levels in newborns
title_sort ppargc1α gene dna methylation variations in human placenta mediate the link between maternal hyperglycemia and leptin levels in newborns
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918074/
https://www.ncbi.nlm.nih.gov/pubmed/27340502
http://dx.doi.org/10.1186/s13148-016-0239-9
work_keys_str_mv AT cotesandra ppargc1agenednamethylationvariationsinhumanplacentamediatethelinkbetweenmaternalhyperglycemiaandleptinlevelsinnewborns
AT gagneouelletvalerie ppargc1agenednamethylationvariationsinhumanplacentamediatethelinkbetweenmaternalhyperglycemiaandleptinlevelsinnewborns
AT guaysimonpierre ppargc1agenednamethylationvariationsinhumanplacentamediatethelinkbetweenmaternalhyperglycemiaandleptinlevelsinnewborns
AT allardcatherine ppargc1agenednamethylationvariationsinhumanplacentamediatethelinkbetweenmaternalhyperglycemiaandleptinlevelsinnewborns
AT houdeandreeanne ppargc1agenednamethylationvariationsinhumanplacentamediatethelinkbetweenmaternalhyperglycemiaandleptinlevelsinnewborns
AT perronpatrice ppargc1agenednamethylationvariationsinhumanplacentamediatethelinkbetweenmaternalhyperglycemiaandleptinlevelsinnewborns
AT baillargeonjeanpatrice ppargc1agenednamethylationvariationsinhumanplacentamediatethelinkbetweenmaternalhyperglycemiaandleptinlevelsinnewborns
AT gaudetdaniel ppargc1agenednamethylationvariationsinhumanplacentamediatethelinkbetweenmaternalhyperglycemiaandleptinlevelsinnewborns
AT guerinrenee ppargc1agenednamethylationvariationsinhumanplacentamediatethelinkbetweenmaternalhyperglycemiaandleptinlevelsinnewborns
AT brissondiane ppargc1agenednamethylationvariationsinhumanplacentamediatethelinkbetweenmaternalhyperglycemiaandleptinlevelsinnewborns
AT hivertmariefrance ppargc1agenednamethylationvariationsinhumanplacentamediatethelinkbetweenmaternalhyperglycemiaandleptinlevelsinnewborns
AT bouchardluigi ppargc1agenednamethylationvariationsinhumanplacentamediatethelinkbetweenmaternalhyperglycemiaandleptinlevelsinnewborns